- Home
- HALO vs LEVI Comparison
HALO vs LEVI Comparison
Compare HALO & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HALO | LEVI |
|---|---|---|
| Founded | 1998 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.1B |
| IPO Year | 2001 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HALO | LEVI |
|---|---|---|
| Price | $67.28 | $19.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $78.18 | $26.31 |
| AVG Volume (30 Days) | 1.8M | ★ 2.2M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | N/A | ★ 178.85 |
| EPS | ★ 2.56 | 1.45 |
| Revenue | $151,862,000.00 | ★ $6,282,000,000.00 |
| Revenue This Year | $28.24 | $7.85 |
| Revenue Next Year | $12.79 | $4.92 |
| P/E Ratio | $26.21 | ★ $13.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.50 | $12.17 |
| 52 Week High | $82.22 | $24.82 |
Technical Indicators
Market Signals| Indicator | HALO | LEVI |
|---|---|---|
| Relative Strength Index (RSI) | 35.07 | 33.93 |
| Support Level | $62.97 | $19.08 |
| Resistance Level | $68.00 | $22.51 |
| Average True Range (ATR) | 2.37 | 0.64 |
| MACD | -0.79 | -0.28 |
| Stochastic Oscillator | 6.69 | 1.88 |
Price Performance
Historical ComparisonAbout HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.